| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.914 | 0.003 | 0.914 | Anticonvulsant | 0.689 0.005 CID_154699994 0.733 0.005 CID_124449 0.906 0.004 CID_107917 | ||
| 0.889 | 0.001 | 0.889 | Benzodiazepine agonist | 0.135 0.011 CID_154699994 0.685 0.002 CID_124449 0.568 0.002 CID_107917 | ||
| 0.871 | 0.002 | 0.871 | GABA A receptor antagonist | 0.064 0.028 CID_154699994 0.642 0.003 CID_124449 0.76 0.002 CID_107917 | ||
| 0.866 | 0.002 | 0.866 | GABA receptor antagonist | 0.071 0.025 CID_154699994 0.631 0.003 CID_124449 0.768 0.002 CID_107917 | ||
| 0.819 | 0.002 | 0.819 | GABA receptor agonist | 0.169 0.027 CID_154699994 0.679 0.003 CID_124449 0.761 0.003 CID_107917 | ||
| 0.654 | 0.004 | 0.654 | GABA C receptor rho-3 antagonist | 0.223 0.181 CID_154699994 0.458 0.039 CID_124449 0.511 0.023 CID_107917 | ||
| 0.523 | 0.007 | 0.523 | Anesthetic general | 0.28 0.039 CID_154699994 0.474 0.01 CID_124449 0.423 0.014 CID_107917 | ||
| 0.487 | 0.012 | 0.487 | Psychostimulant | 0.446 0.016 CID_154699994 0.369 0.028 CID_124449 0.413 0.02 CID_107917 | ||
| 0.456 | 0.013 | 0.456 | Platelet aggregation inhibitor | 0.178 0.099 CID_154699994 0.203 0.079 CID_124449 0.223 0.066 CID_107917 | ||
| 0.418 | 0.005 | 0.418 | Platelet activating factor antagonist | 0.193 0.028 CID_124449 0.178 0.033 CID_107917 | ||
| 0.435 | 0.022 | 0.435 | HERG channel blocker | 0.164 0.115 CID_107917 | ||
| 0.425 | 0.023 | 0.425 | Potassium channel (Voltage-sensitive) blocker | 0.157 0.131 CID_107917 | ||
| 0.39 | 0.002 | 0.39 | Benzodiazepine antagonist | 0.058 0.015 CID_154699994 0.126 0.003 CID_124449 0.127 0.003 CID_107917 | ||
| 0.457 | 0.107 | 0.571 | Antiinflammatory | 0.478 0.097 CID_154699994 0.571 0.062 CID_107917 | CID_107917 | |
| 0.401 | 0.084 | 0.401 | Analgesic | 0.351 0.108 CID_107917 | ||
| 0.345 | 0.034 | 0.345 | Potassium channel blocker | |||
| 0.305 | 0.004 | 0.305 | GABA A receptor agonist | 0.107 0.032 CID_124449 0.262 0.005 CID_107917 | ||
| 0.256 | 0.01 | 0.256 | GABA C receptor rho-2 antagonist | 0.161 0.061 CID_124449 0.185 0.038 CID_107917 | ||
| 0.308 | 0.078 | 0.44 | Immunomodulator | 0.44 0.034 CID_154699994 0.325 0.069 CID_107917 | CID_154699994 | |
| 0.229 | 0.02 | 0.229 | Sodium channel (voltage-gated) blocker | 0.11 0.097 CID_124449 0.188 0.034 CID_107917 | ||
| 0.209 | 0.029 | 0.209 | Sodium channel blocker | 0.147 0.06 CID_107917 | ||
| 0.174 | 0.013 | 0.174 | Potassium channel activator | 0.121 0.032 CID_124449 0.092 0.058 CID_107917 | ||
| 0.192 | 0.031 | 0.192 | MAP kinase kinase inhibitor | 0.118 0.076 CID_124449 | ||
| 0.26 | 0.1 | 0.298 | Nootropic | 0.298 0.075 CID_107917 | CID_107917 | |
| 0.162 | 0.014 | 0.162 | Interleukin 2 antagonist | 0.128 0.034 CID_124449 0.113 0.057 CID_107917 | ||
| 0.156 | 0.019 | 0.156 | p38 MAP kinase inhibitor | 0.092 0.035 CID_107917 | ||
| 0.143 | 0.011 | 0.143 | Bromodomain-containing protein 2 inhibitor | 0.09 0.056 CID_124449 0.083 0.07 CID_107917 | ||
| 0.162 | 0.034 | 0.162 | Pregnane X receptor agonist | 0.134 0.089 CID_124449 0.138 0.079 CID_107917 | ||
| 0.145 | 0.019 | 0.145 | MAP kinase kinase 1 inhibitor | 0.126 0.03 CID_124449 0.09 0.071 CID_107917 | ||
| 0.134 | 0.017 | 0.134 | Glutamate (mGluR group I) antagonist | |||
| 0.218 | 0.104 | 0.218 | Cardiotonic | |||
| 0.159 | 0.047 | 0.159 | MAP kinase kinase 4 inhibitor | 0.131 0.112 CID_154699994 0.153 0.055 CID_124449 0.147 0.069 CID_107917 | ||
| 0.134 | 0.027 | 0.138 | Alcohol dehydrogenase inhibitor | 0.089 0.065 CID_154699994 0.138 0.025 CID_124449 0.088 0.067 CID_107917 | CID_124449 | |
| 0.115 | 0.008 | 0.115 | Glutamate (mGluR5) antagonist | 0.046 0.033 CID_124449 | ||
| 0.121 | 0.017 | 0.121 | Nav1.7 sodium channel blocker | 0.075 0.038 CID_107917 | ||
| 0.165 | 0.065 | 0.165 | Cyclin-dependent kinase 8 inhibitor | |||
| 0.123 | 0.025 | 0.123 | Glutamate (mGluR) antagonist | |||
| 0.305 | 0.206 | 0.305 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.1 | 0.004 | 0.1 | Benzodiazepine inverse agonist | 0.054 0.019 CID_154699994 0.086 0.005 CID_107917 | ||
| 0.149 | 0.055 | 0.149 | Nav1.6 sodium channel blocker | 0.148 0.056 CID_124449 | ||
| 0.136 | 0.043 | 0.136 | MAP kinase 13 inhibitor | 0.125 0.051 CID_124449 0.095 0.089 CID_107917 | ||
| 0.124 | 0.037 | 0.124 | GABA C receptor rho-1 antagonist | 0.091 0.076 CID_107917 | ||
| 0.136 | 0.053 | 0.136 | MAP kinase 12 inhibitor | 0.127 0.061 CID_124449 0.103 0.094 CID_107917 | ||
| 0.087 | 0.004 | 0.092 | Benzodiazepine receptor peripheral-type antagonist | 0.042 0.012 CID_154699994 0.092 0.004 CID_124449 0.064 0.005 CID_107917 | CID_124449 | |
| 0.128 | 0.045 | 0.128 | GABA C receptor antagonist | 0.096 0.084 CID_107917 | ||
| 0.135 | 0.062 | 0.135 | Glutamate receptor antagonist | |||
| 0.098 | 0.026 | 0.098 | Transforming growth factor beta 3 antagonist | 0.08 0.063 CID_124449 0.085 0.048 CID_107917 | ||
| 0.123 | 0.051 | 0.123 | CDK3/cyclin E inhibitor | 0.115 0.063 CID_107917 | ||
| 0.103 | 0.034 | 0.103 | MAP kinase 14 inhibitor | |||
| 0.085 | 0.016 | 0.085 | Phosphodiesterase 1C inhibitor | 0.06 0.048 CID_124449 | ||
| 0.108 | 0.045 | 0.115 | Lanosterol 14 alpha demethylase inhibitor | 0.092 0.069 CID_124449 0.115 0.036 CID_107917 | CID_107917 | |
| 0.074 | 0.011 | 0.074 | Bromodomain-containing protein 3 inhibitor | 0.06 0.021 CID_124449 0.048 0.036 CID_107917 | ||
| 0.076 | 0.019 | 0.076 | Phosphodiesterase 1A inhibitor | |||
| 0.115 | 0.06 | 0.115 | 5 Hydroxytryptamine 3A agonist | |||
| 0.074 | 0.021 | 0.074 | Phosphodiesterase II inhibitor | 0.05 0.047 CID_107917 | ||
| 0.174 | 0.125 | 0.174 | ErbB-1 antagonist | 0.164 0.145 CID_107917 | ||
| 0.058 | 0.009 | 0.058 | 5 Hydroxytryptamine 2B agonist | |||
| 0.203 | 0.156 | 0.203 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.195 0.179 CID_107917 | ||
| 0.074 | 0.027 | 0.074 | Phosphodiesterase 1B inhibitor | |||
| 0.066 | 0.02 | 0.066 | Phosphodiesterase 2A inhibitor | |||
| 0.06 | 0.02 | 0.06 | Farnesyltransferase inhibitor | 0.053 0.025 CID_107917 | ||
| 0.099 | 0.059 | 0.099 | Pim-1 kinase inhibitor | 0.081 0.08 CID_124449 | ||
| 0.054 | 0.016 | 0.054 | GABA B receptor antagonist | 0.048 0.022 CID_107917 | ||
| 0.083 | 0.046 | 0.083 | Nicotinic alpha4beta2 receptor antagonist | |||
| 0.062 | 0.027 | 0.062 | Dihydroorotate dehydrogenase inhibitor | 0.052 0.035 CID_124449 0.049 0.039 CID_107917 | ||
| 0.069 | 0.039 | 0.069 | Aryl hydrocarbon receptor antagonist | |||
| 0.112 | 0.083 | 0.112 | Nav1.3 sodium channel blocker | |||
| 0.036 | 0.006 | 0.036 | Geranylgeranyltransferase I inhibitor | 0.031 0.008 CID_107917 | ||
| 0.064 | 0.035 | 0.064 | Potassium channel intermediate-conductance Ca-activated blocker | |||
| 0.052 | 0.024 | 0.052 | Cholecystokinin antagonist | 0.035 0.032 CID_124449 | ||
| 0.049 | 0.023 | 0.049 | Parathyroid hormone antagonist | 0.043 0.037 CID_124449 0.047 0.028 CID_107917 | ||
| 0.087 | 0.062 | 0.087 | Pim-3 kinase inhibitor | |||
| 0.071 | 0.047 | 0.071 | Transforming growth factor antagonist | |||
| 0.113 | 0.089 | 0.113 | Phosphodiesterase inhibitor | |||
| 0.063 | 0.039 | 0.063 | Corticotropin releasing factor 2 receptor antagonist | |||
| 0.05 | 0.032 | 0.05 | Purinergic P2X antagonist | |||
| 0.075 | 0.061 | 0.075 | Viral attachment inhibitor | |||
| 0.053 | 0.042 | 0.053 | Phosphodiesterase 4C inhibitor | |||
| 0.13 | 0.121 | 0.13 | LIM domain kinase 1 inhibitor | |||
| 0.036 | 0.027 | 0.036 | Cholecystokinin A antagonist | |||
| 0.052 | 0.043 | 0.052 | Bromodomain-containing protein 4 inhibitor | |||
| 0.075 | 0.066 | 0.075 | 5 Hydroxytryptamine 2C antagonist | |||
| 0.091 | 0.083 | 0.091 | Hedgehog signaling inhibitor | |||
| 0.051 | 0.044 | 0.051 | Pim-2 kinase inhibitor | |||
| 0.047 | 0.041 | 0.047 | 5 Hydroxytryptamine 2 agonist | |||
| 0.081 | 0.075 | 0.081 | Phosphodiesterase I inhibitor | |||
| 0.107 | 0.103 | 0.107 | Cytokine production inhibitor | |||
| 0.097 | 0.094 | 0.097 | TRKA antagonist | |||
| 0.055 | 0.053 | 0.055 | Potassium channel (Ca-activated) blocker | |||
| 0.024 | 0.022 | 0.024 | Kynurenine 3 monooxygenase inhibitor | 0.024 0.021 CID_107917 | ||
| 0.082 | 0.082 | 0.097 | DNA directed RNA polymerase inhibitor | 0.097 0.06 CID_154699994 | CID_154699994 | |
| 0.035 | 0.048 | 0.042 | CF transmembrane conductance regulator antagonist | 0.042 0.021 CID_107917 | CID_107917 | |
| 0.057 | 0.084 | 0.067 | Protein kinase B beta inhibitor | 0.067 0.062 CID_124449 | CID_124449 | |
| 0.129 | 0.161 | 0.162 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.162 0.113 CID_124449 | CID_124449 | |
| 0.137 | 0.178 | 0.307 | Interleukin agonist | 0.307 0.045 CID_154699994 0.166 0.152 CID_107917 | CID_154699994 | |
| 0.081 | 0.159 | 0.112 | Interleukin 8 antagonist | 0.112 0.072 CID_124449 | CID_124449 | |
| 0.094 | 0.181 | 0.2 | NOS3 expression enhancer | 0.2 0.041 CID_154699994 | CID_154699994 | |
| 0.132 | 0.221 | 0.183 | MAP-kinase-activated kinase 5 inhibitor | 0.183 0.127 CID_124449 | CID_124449 | |
| 0.159 | 0.262 | 0.269 | Toll-Like receptor 7 agonist | 0.269 0.131 CID_107917 | CID_107917 | |
| 0.09 | 0.193 | 0.141 | Insulin secretagoues | 0.141 0.084 CID_154699994 | CID_154699994 | |
| 0.153 | 0.271 | 0.267 | Toll-Like receptor agonist | 0.267 0.134 CID_107917 | CID_107917 | |
| 0.059 | 0.179 | 0.091 | Beta glucuronidase inhibitor | 0.091 0.085 CID_124449 | CID_124449 | |
| 0.054 | 0.201 | 0.115 | Cyclooxygenase 1 inhibitor | 0.115 0.085 CID_107917 | CID_107917 | |
| 0.103 | 0.266 | 0.216 | Cyclic AMP phosphodiesterase inhibitor | 0.216 0.083 CID_154699994 | CID_154699994 | |
| 0.058 | 0.236 | 0.102 | Aldehyde dehydrogenase inhibitor | 0.102 0.094 CID_154699994 | CID_154699994 | |
| 0.056 | 0.237 | 0.118 | Protein kinase C nu inhibitor | 0.118 0.095 CID_124449 | CID_124449 | |
| 0.112 | 0.316 | 0.208 | RNA-directed DNA polymerase inhibitor | 0.208 0.088 CID_154699994 | CID_154699994 | |
| 0.106 | 0.312 | 0.3 | DNA synthesis inhibitor | 0.3 0.044 CID_154699994 | CID_154699994 | |
| 0.117 | 0.325 | 0.276 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.276 0.083 CID_124449 | CID_124449 | |
| 0.037 | 0.299 | 0.095 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.095 0.059 CID_154699994 | CID_154699994 | |
| 0.024 | 0.288 | 0.195 | Topoisomerase I inhibitor | 0.195 0.028 CID_154699994 | CID_154699994 | |
| 0.051 | 0.373 | 0.126 | Hexokinase inhibitor | 0.126 0.109 CID_154699994 | CID_154699994 | |
| 0.032 | 0.393 | 0.09 | NADH dehydrogenase inhibitor | 0.09 0.057 CID_154699994 | CID_154699994 | |
| 0.005 | 0.417 | 0.016 | S-adenosyl-L-homocysteine hydrolase inhibitor | 0.016 0.009 CID_154699994 | CID_154699994 | |
| 0.023 | 0.441 | 0.092 | Uric acid excretion stimulant | 0.092 0.062 CID_154699994 | CID_154699994 | |
| 0.017 | 0.537 | 0.091 | AMP-activated protein kinase stimulant | 0.091 0.085 CID_154699994 | CID_154699994 | |
| 0.02 | 0.586 | 0.06 | Adenine nucleotide translocase inhibitor | 0.06 0.029 CID_154699994 | CID_154699994 | |
| 0.009 | 0.609 | 0.051 | Protein 50S ribosomal subunit inhibitor | 0.051 0.038 CID_154699994 | CID_154699994 | |
| 0.029 | 0.654 | 0.263 | Immunosuppressant | 0.263 0.138 CID_154699994 | CID_154699994 | |
| 0.041 | 0.675 | 0.233 | Cyclophilin D inhibitor | 0.233 0.232 CID_154699994 | CID_154699994 | |
| 0.003 | 0.643 | 0.034 | Adenosine A1 receptor agonist | 0.034 0.009 CID_154699994 | CID_154699994 | |
| 0.027 | 0.67 | 0.217 | Antibacterial | 0.217 0.21 CID_154699994 | CID_154699994 | |
| 0.004 | 0.686 | 0.014 | Adenosine A2b receptor agonist | 0.014 0.011 CID_154699994 | CID_154699994 | |
| 0.004 | 0.691 | 0.018 | Adenosine A3 receptor agonist | 0.018 0.011 CID_154699994 | CID_154699994 | |
| 0.024 | 0.767 | 0.168 | Hypoglycemic | 0.168 0.15 CID_154699994 | CID_154699994 | |
| 0.018 | 0.87 | 0.151 | Hepatoprotectant | 0.151 0.109 CID_154699994 | CID_154699994 | |
| 0.005 | 0.862 | 0.093 | Aminoacyl-tRNA synthetase inhibitor | 0.093 0.055 CID_154699994 | CID_154699994 | |
| 0.002 | 0.864 | 0.024 | Purinergic P2X agonist | 0.024 0.021 CID_154699994 | CID_154699994 | |
| 0.01 | 0.878 | 0.16 | Platelet adhesion inhibitor | 0.16 0.096 CID_154699994 | CID_154699994 | |
| 0.012 | 0.914 | 0.133 | DNA polymerase I inhibitor | 0.133 0.059 CID_154699994 | CID_154699994 | |
| 0.042 | 0.957 | 0.291 | Peptidyltransferase inhibitor | 0.291 0.028 CID_154699994 | CID_154699994 | |
| 0.005 | 0.971 | 0.174 | Angiogenesis stimulant | 0.174 0.108 CID_154699994 | CID_154699994 | |
| 0.002 | 0.977 | 0.03 | 1,3-Beta-glucan synthase inhibitor | 0.03 0.014 CID_124449 | CID_124449 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |